medigraphic.com
ISSN 0016-3813 (Print)

2006, Number 6

<< Back Next >>

Gac Med Mex 2006; 142 (6)

A 54 years old women with heartbeats, blurred vision, mental confusión, and hypoglycemia.

Ríos-Vaca A, Sierra-Ascencio ME, Reza-Albarrán A, Gonzáles-Jordán JL, Martínez-Benítez B

Language: Spanish
References: 16
Page: 501-505
PDF size: 489.33 Kb.


Text Extraction

No abstract


REFERENCES

  1. Bolli BB. Hypoglycemia in type 1 diabetes mellitus. EN: Endocrinology and Metabolism. Pinchera A (Ed). McGraw-Hill. 1ra Edición Berkshire, 2001, pp 655-662.

  2. Davidson MB. Hipoglucemia en la edad adulta. EN: Endocrinología y Metabolismo. Lavin N (Ed). Marbán. 3ra Edición Madrid, 2003, pp. 512-532.

  3. Cryer PE. Glucose Homeostasis and Hypoglycemia. EN: Williams Textbook of Endocrinology. Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (Eds). Saunders. 10a. Edición Philadeplhia, 2003, pp 1599-1610.

  4. Mehta R. Hipoglucemia. EN: Manual de terapéutica médica y procedimientos de urgencias. Gutiérrez-Cirlos C, Cárdenas-Cortes M, Catzin-Kuhlmann A (Ed). McGraw-Hill Interamericana. 5ta Edición. México D.F., 2006, pp 238-244.

  5. Rodríguez-Vallejo F, Ríos-Torres JM, Gómez-Pérez FJ, et al. Associations of patterns in the oral glucose tolerance test and different clinical features in patients with insulinoma. Endoc Pract 2005;11(Supp1):28.

  6. Service FJ. Hypoglycemic disorders. N Engl J Med 1995;332:1144-1152.

  7. Hirshberg B, Livi A, Bartlett DL, Libutti SK, Alexander HR, Doppman JL, et al. Forty-eight-hour fast: the diagnostic test for insulinoma. J Clin Endocrinol Metab 2000;85:3222-3226.

  8. López-Alvarenga JC, Cáceres-Agreda N, Rivera L, Gamboa A, Gómez-Pérez FJ, Rull JA. Diagnóstico de insulinomas malignos y benignos. Experiencia en el Instituto Nacional de la Nutrición. Rev Invest Clin 1999;51:167-173.

  9. Piovesan A, Pia A, Visconti G, Terzolo M, Leone A, Magro G, et al. Proinsulin-secreting neuroendocrine tumor of the pancreas. J Endocrinol Invest 2003;26:758-761.

  10. Power N, Reznek RH. Imaging pancreatic islet cell tumours. Imaging 2002; 14:147-159.

  11. Doppman JL, Chang R, Fraker DL, Norton JA, Alexander HR, Miller DL, et al. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med 1995;123:269-273.

  12. Service FJ, McMahon MM. Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991;66:711-719.

  13. Lechago J. Gastrointestinal neuroendocrine cell proliferations. Hum Pathol. 1994;25:1114-1122.

  14. Heitz PU, Kasper M, Polak JM, Kloppel. Pancreatic endocrine tumors. Hum Pathol 1982;13:263-271.

  15. Hochwald SN, Zee S, Conlon KC, Colleoni R, Louie O, Brennan MF, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol. 2002;20:2633-2642.

  16. Pelosi G, Bresaola E, Bogina G, Pasini F, Rodella S, Castelli P, et al. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol 1996;27:1124-1134.




2020     |     www.medigraphic.com